학술논문
Thiamidol® in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase
Document Type
Article
Source
In: Journal of Dermatology . (Journal of Dermatology, December 2021, 48(12):1871-1876)
Subject
Language
English
ISSN
13468138
03852407
03852407